Antitumor AHMA linked to DNA minor groove binding agents: Synthesis and biological evaluation

Kamesh Rastogi, Jang Yang Chang, Wen Yu Pan, Ching Huang Chen, Ting Chao Chou, Li Tzong Chen, Tsann Long Su

研究成果: 雜誌貢獻文章同行評審

40 引文 斯高帕斯(Scopus)


DNA minor groove binder hybrid molecules, netropsin derivatives such as N-[2-(dimethylamino)-ethyl]-1-methyl-4-aminopyrrolo-2-carboxamide (MePy) or its derivatives containing two units of N-methylpyrrolecarboxamide (diMePy) and bisbenzimidazole (Ho33258), were linked to the NH2 function of AHMA or to the CH2OH group of AHMA-ethylcarbamate to form AHMA-N-netropsins (13-16) and AHMA-ethylcarbamate-O-netropsins (19-22), and AHMA-bisbenzimidazole (AHMA-Ho33258, 25), respectively. These conjugates' in vitro antitumor activity, inhibition of a variety of human tumor cell growth, revealed that AHMA-ethylcarbamate-O-netropsin derivatives were more cytotoxic than AHMA-N-netropsin compounds. In the same studies, all compounds bearing MePy were more potent than those compounds linked with diMePy. Moreover, AHMA-netropsin derivatives bearing a succinyl chain as the linking spacer were more potent than those compounds having a glutaryl bridge. Among these hybrid molecules, AHMA-ethylcarbamate-O-succinyl-MePy (19) was 2- to 6-fold more cytotoxic than the parent compound AHMA (5) in various cell lines, whereas compound 25 had very poor solubility and was inactive. Studies on the inhibitory effect against topoisomerase II (Topo II) and DNA interaction of these conjugates showed no correlation between the potency of DNA binding and inhibitory activity against Topo II.
頁(從 - 到)4485-4493
期刊Journal of Medicinal Chemistry
出版狀態已發佈 - 9月 2002

ASJC Scopus subject areas

  • 分子醫學
  • 藥物發現


深入研究「Antitumor AHMA linked to DNA minor groove binding agents: Synthesis and biological evaluation」主題。共同形成了獨特的指紋。